Topline results from the phase 3 HERIZON-GEA-01 trial show that the HER2-targeted bispecific antibody zanidatamab-hrii ...
The Cool Down on MSN
New study finds concerning link between common hair product and cancer: 'One more thing women can do to reduce their risk'
The study also showed that it impacts Black women disproportionately. New study finds concerning link between common hair product and cancer: 'One more thing women can do to reduce their risk' first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback